Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14409
Articles
Company
Deals
Shandong Luoxin Partners with Shanghai Pharma for Strategic Services
February 5, 2025
Policy / Regulatory
NHSA Releases Guide on Volume-Based Procurement Drug Equivalents
February 5, 2025
Company
Drug
Zelgen Biopharmaceuticals Gains NMPA Approval for Jacktinib Clinical Trial in SLE
February 5, 2025
Company
Deals
F-star Therapeutics’ Takeover by Sino Biopharmaceutical Delayed Amid CFIUS Review
February 5, 2025
Company
Deals
Shenzhen NeuroPlus Secures Seed Funding for Neuromodulation and Bioelectronic Medicine
February 5, 2025
Company
Merck KGaA Opens Viral Clearance Lab in Shanghai’s Biologics Testing Center
February 5, 2025
Company
Deals
METiS Therapeutics In-Licenses Voronoi’s Pan-RAF Inhibitor Program
February 5, 2025
Policy / Regulatory
Heilongjiang Launches ‘Longjiang Huiminbao’ Supplementary Health Insurance Scheme
February 5, 2025
Company
Deals
Immuno Cure BioTech Acquires Majority Stake in Shanghai Teresa Healthcare
February 6, 2025
Company
Drug
Lepu Biotechnology’s MRG003 Receives Orphan Drug Designation from FDA
February 11, 2025
Company
Deals
Kamari Pharma Completes $8M Investment from Chinese Fund GIBF2
February 6, 2025
Company
Drug
Joincare’s Modified Drug XYP-001 Gains NMPA Approval for IPF Trial
February 6, 2025
1
2
…
1,128
1,129
1,130
1,131
1,132
…
1,200
1,201
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?